Diabetes Medications: Cardiovascular and Kidney Impact
Related Articles
- Keep Recent Evidence of Dementia Risk in Perspective
- Stay Current on Med Recommendations for Diabetes
- Know How Inpefa Stacks Up to Other SGLT2 Inhibitors
- Evaluate Treatments for Kidney Disease and Diabetes
- Address SGLT2 Inhibitor Use in the Hospital
- Know the Role of Jardiance for HFpEF
- Don’t Jump to SGLT2 Inhibitors for Patients WithOUT Diabetes
- Think of Sulfonylureas as CV Neutral
- Don't Jump to an SGLT2 Inhibitor for Heart Failure
- Compare Cardiovascular Benefits of SGLT2 Inhibitors for Type 2 Diabetes
- Compare New GLP-1 Agonist and Flozin Options for Type 2 Diabetes
- Consider Whether Flozin Benefits Outweigh Risks
- Consider Risks and Benefits When Choosing Metformin Add-Ons
- <em>Jardiance</em> (empagliflozin) improving CV outcomes
- Consider Cardiovascular Benefits When Choosing Metformin Add-ons